<DOC>
	<DOCNO>NCT01769625</DOCNO>
	<brief_summary>This biomarker study goal measure change protein gene methylation . This study intend use diagnosing , mitigate , treat , cure , prevent disease . The purpose study determine Vitamin D ( cholecalciferol ) alone combination celecoxib ( Celebrex , non-steroidal anti-inflammatory drug , NSAID ) , act together decrease breast cancer risk effect certain biological indicator ( biomarkers ) breast cancer risk ( call PGE2 , COX-2 , 15-PGDH ) cell change breast .</brief_summary>
	<brief_title>Changes Biomarkers Using Prostaglandin Inhibitors</brief_title>
	<detailed_description>This biomarker study goal measure change protein rna expression . This study intend use diagnosing , mitigate , treat , cure , prevent disease . 66 woman normal risk develop breast cancer recruit enrol . 22 woman randomize arm , anticipation 2 woman group evaluable , leave 20 group evaluation . A combination vitamin D celecoxib act synergistically decrease breast cancer risk decrease cell proliferation mammary epithelium action prostaglandin synthesis metabolism . Specific Aims : -Evaluate vitamin D metabolism , measurement CYP24 breast . 2-Evaluate breast specific level vitamin D celecoxib , ass level compound correlate response marker influence prostaglandin synthesis metabolism . Additionally , woman without active breast cancer , determine effect vitamin D , without celecoxib , 1 ) PG synthesis metabolism , measurement PGE2 , COX-2 15-PGDH breast , 2 ) proliferative activity breast , , 3 ) circulating level vitamin D celecoxib , determine level compound correlate response marker PG production , metabolism , cell proliferation .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Woman &gt; 18 year old Healthy woman normal risk develop breast cancer ECOG Performance Status score 01 Premenopausal woman must pregnant History bilateral mastectomy , bilateral breast irradiation Significant medical psychiatric problem make participant poor candiate Evidence excess use narcotic drug dependency Have pregnant lactating past 2 year Significant history peptic ulcer disease upper gastrointestinal bleeding History severe congestive heart failure require hospitalization intervention History asthma require medication treatment Allergy sulfonamide NSAID medication History myocardial infarction stroke Currently Coumadin Currently Tamoxifen ( nolvadex ) , Evista ( raloxifene ) , Femara ( letrozole ) , Arimidex ( anastrozole ) , Aromasin ( exemestane ) Undergone prior subaeolar breast surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>breast</keyword>
	<keyword>high risk woman</keyword>
	<keyword>biomarkers</keyword>
	<keyword>vitamin D</keyword>
</DOC>